Goodbye job applications, hello dream career
Seize control of your career and design the future you deserve with LW career

Sydney Surgical Centre sold to Cura Day Hospitals Group

National law firm Hall & Wilcox has advised Captia Pty Limited as the trustee of the Captia Trust in relation to the sale of Sydney Surgical Centre to the Cura Day Hospitals Group.

user iconJerome Doraisamy 07 March 2023 Big Law
expand image

Firm: Hall & Wilcox (Captia).

Deal: The Sydney Surgical Centre has been sold to the Cura Day Hospitals Group, with Captia being advised in relation to the sale, including the transfer of the lease, employees and business and assets, liaising with the solicitors who acted for the vendors, the shareholders and unitholders.

Area: Corporate


Value: Undisclosed

Key players: The Hall & Wilcox team was led by partner Alison Choy Flannigan, who was supported by partner Mark Petrucco and lawyers James Blok and James Pinkerton, as well as partner Maurice Doria and lawyer Lada Notova.

Deal significance: Speaking about the sale, Ms Choy Flannigan said: “One of the challenges of this deal was working with so many stakeholders, and COVID-19 caused a lot of disruption to the private hospital market. The sale was a great result for all concerned.”

Captia chair Stephanie Watson added: “Sydney Surgical Centre was established by the medical practitioner group of shareholders to provide excellence in care to patients having surgery.

“We are pleased that the sale to Cura enables the centre to continue providing high-quality patient care and support to our staff and surgeons. Working with Hall & Wilcox enabled us to realise these gains from the sale. We were grateful for the expertise of the team led by partner Alison Choy Flannigan.”

And Sydney Surgical Centre chief executive Tony Scaramuzza said: “Alison Choy Flannigan’s specialised experience and understanding of the private hospitals and health care sectors, supported by the breadth and strength of the Hall & Wilcox team, was instrumental in navigating this complex transaction and achieving an excellent outcome for our patients, doctors, staff, suppliers and shareholders.”